Oxidative Stress-Induced Signaling Pathways Implicated in the Pathogenesis of Parkinson’s Disease

[1]  Xinglong Wang,et al.  Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. , 2013, Free radical biology & medicine.

[2]  Xiaochun Chen,et al.  Astaxanthin Suppresses MPP+-Induced Oxidative Damage in PC12 Cells through a Sp1/NR1 Signaling Pathway , 2013, Marine drugs.

[3]  Hey-kyeong Jeong,et al.  PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices , 2013, Experimental neurobiology.

[4]  Y. Kitagishi,et al.  Function and Characteristics of PINK1 in Mitochondria , 2013, Oxidative medicine and cellular longevity.

[5]  S. Gonfloni,et al.  Parkinson’s Disease: A Complex Interplay of Mitochondrial DNA Alterations and Oxidative Stress , 2013, International journal of molecular sciences.

[6]  S. Cardoso,et al.  Mitochondria drive autophagy pathology via microtubule disassembly , 2013, Autophagy.

[7]  X. Zhuang,et al.  Characterization of PINK1 (PTEN-induced Putative Kinase 1) Mutations Associated with Parkinson Disease in Mammalian Cells and Drosophila* , 2013, The Journal of Biological Chemistry.

[8]  L. Martins,et al.  Drosophila Trap1 protects against mitochondrial dysfunction in a PINK1/parkin model of Parkinson's disease , 2013, Cell Death and Disease.

[9]  U. Landegren,et al.  Elevated MARK2-dependent phosphorylation of Tau in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[10]  Yong-jun Wang,et al.  Human neuromelanin: an endogenous microglial activator for dopaminergic neuron death. , 2013, Frontiers in bioscience.

[11]  Y. Michotte,et al.  Oxidative Stress in Genetic Mouse Models of Parkinson's Disease , 2012, Oxidative medicine and cellular longevity.

[12]  I. Novak,et al.  Mitophagy: a complex mechanism of mitochondrial removal. , 2012, Antioxidants & redox signaling.

[13]  G. Cesareni,et al.  Oxidative Stress, DNA Damage, and c-Abl Signaling: At the Crossroad in Neurodegenerative Diseases? , 2012, International journal of cell biology.

[14]  Carol S. Lim,et al.  Selective Targeting of c-Abl via a Cryptic Mitochondrial Targeting Signal Activated by Cellular Redox Status in Leukemic and Breast Cancer Cells , 2012, Pharmaceutical Research.

[15]  Jianhua Zhang,et al.  Genetically engineered mouse models of Parkinson's disease , 2012, Brain Research Bulletin.

[16]  O. Elemento,et al.  Concordant Signaling Pathways Produced by Pesticide Exposure in Mice Correspond to Pathways Identified in Human Parkinson's Disease , 2012, PloS one.

[17]  David S. Park,et al.  Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment , 2012, EMBO reports.

[18]  S. Pluchino,et al.  Plasticity of Subventricular Zone Neuroprogenitors in MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine) Mouse Model of Parkinson's Disease Involves Cross Talk between Inflammatory and Wnt/β-Catenin Signaling Pathways: Functional Consequences for Neuroprotection and Repair , 2012, The Journal of Neuroscience.

[19]  E. Mandelkow,et al.  Microtubule Affinity-regulating Kinase 2 (MARK2) Turns on Phosphatase and Tensin Homolog (PTEN)-induced Kinase 1 (PINK1) at Thr-313, a Mutation Site in Parkinson Disease , 2012, The Journal of Biological Chemistry.

[20]  N. Hattori,et al.  PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria , 2012, Nature Communications.

[21]  R. Uitti,et al.  Autosomal dominant Parkinson's disease. , 2012, Parkinsonism & related disorders.

[22]  A. Brice,et al.  Role of mendelian genes in "sporadic" Parkinson's disease. , 2012, Parkinsonism & related disorders.

[23]  Hey-kyeong Jeong,et al.  Spatial and temporal correlation in progressive degeneration of neurons and astrocytes in contusion-induced spinal cord injury , 2012, Journal of Neuroinflammation.

[24]  D. Surmeier,et al.  The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease , 2011, Neuroscience.

[25]  F. Costantini,et al.  Downregulation of Wnt/β-catenin signaling causes degeneration of hippocampal neurons in vivo , 2011, Neurobiology of Aging.

[26]  H. Reichmann.  View point: Etiology in Parkinson's disease. Dual hit or spreading intoxication , 2011, Journal of the Neurological Sciences.

[27]  Christine Van Broeckhoven,et al.  Parkinson disease: Insights in clinical, genetic and pathological features of monogenic disease subtypes , 2011, Journal of Chemical Neuroanatomy.

[28]  A. Brice,et al.  What genetics tells us about the causes and mechanisms of Parkinson's disease. , 2011, Physiological reviews.

[29]  S. Lipton,et al.  Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases , 2011, Cell Death and Differentiation.

[30]  S. Pluchino,et al.  A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection , 2011, Molecular Neurodegeneration.

[31]  G. Martino,et al.  Corrigendum to “Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease” [Neurobiol. Dis. 41/2 (2011) 508–527] , 2011, Neurobiology of Disease.

[32]  D. Selkoe,et al.  The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking , 2011, Journal of neurochemistry.

[33]  A. Mahadevan,et al.  Evaluation of Markers of Oxidative Stress, Antioxidant Function and Astrocytic Proliferation in the Striatum and Frontal Cortex of Parkinson’s Disease Brains , 2011, Neurochemical Research.

[34]  R. Rodenburg,et al.  Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance , 2011, Journal of Cell Science.

[35]  M. Beal,et al.  Molecular insights into Parkinson's disease , 2011, F1000 medicine reports.

[36]  R. Huber,et al.  HTRA proteases: regulated proteolysis in protein quality control , 2011, Nature Reviews Molecular Cell Biology.

[37]  J. Siegenthaler,et al.  Wnt Signaling Regulates Neuronal Differentiation of Cortical Intermediate Progenitors , 2011, The Journal of Neuroscience.

[38]  E. Melamed,et al.  Wnt signaling pathway overcomes the disruption of neuronal differentiation of neural progenitor cells induced by oligomeric amyloid β‐peptide , 2011, Journal of neurochemistry.

[39]  G. Martino,et al.  Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease , 2011, Neurobiology of Disease.

[40]  Philip L De Jager,et al.  Parkinson's disease: genetics and pathogenesis. , 2011, Annual review of pathology.

[41]  R. Akundi,et al.  Increased Mitochondrial Calcium Sensitivity and Abnormal Expression of Innate Immunity Genes Precede Dopaminergic Defects in Pink1-Deficient Mice , 2011, PloS one.

[42]  A. J. Valente,et al.  Novel Regulation of Parkin Function through c-Abl-Mediated Tyrosine Phosphorylation: Implications for Parkinson's Disease , 2011, The Journal of Neuroscience.

[43]  Jian-ning Zhang,et al.  The Wnt /β‐catenin signaling pathway in the adult neurogenesis , 2011, The European journal of neuroscience.

[44]  A. Whitworth,et al.  PINK1 cleavage at position A103 by the mitochondrial protease PARL , 2010, Human molecular genetics.

[45]  S. Prabhakar,et al.  Altered oxidative stress levels in Indian Parkinson's disease patients with PARK2 mutations. , 2011, Acta biochimica Polonica.

[46]  M. Sakaguchi,et al.  A New Cytosolic Pathway from a Parkinson Disease-associated Kinase, BRPK/PINK1 , 2010, The Journal of Biological Chemistry.

[47]  E. Medina,et al.  Phosphatidylinositol 3-Kinase Activation Attenuates the TLR2-Mediated Macrophage Proinflammatory Cytokine Response to Francisella tularensis Live Vaccine Strain , 2010, The Journal of Immunology.

[48]  Paul T. Schumacker,et al.  Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1 , 2010, Nature.

[49]  B. Li,et al.  Omi/HtrA2 is a positive regulator of autophagy that facilitates the degradation of mutant proteins involved in neurodegenerative diseases , 2010, Cell Death and Differentiation.

[50]  Hey-kyeong Jeong,et al.  Inflammatory Responses Are Not Sufficient to Cause Delayed Neuronal Death in ATP-Induced Acute Brain Injury , 2010, PloS one.

[51]  Robert A. Smith,et al.  Toxicological and pathophysiological roles of reactive oxygen and nitrogen species. , 2010, Toxicology.

[52]  Xin Sun,et al.  Tetrahydroxystilbene glucoside attenuates MPP+-induced apoptosis in PC12 cells by inhibiting ROS generation and modulating JNK activation , 2010, Neuroscience Letters.

[53]  M. Horowitz,et al.  Gene–Environment Interactions in Parkinson's Disease: The Importance of Animal Modeling , 2010, Clinical pharmacology and therapeutics.

[54]  J. Troncoso,et al.  Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function , 2010, Proceedings of the National Academy of Sciences.

[55]  L. Yin,et al.  Terminal differentiation of chronic myelogenous leukemia cells is induced by targeting of the MUC1-C oncoprotein , 2010, Cancer biology & therapy.

[56]  C. Tirolo,et al.  Glia as a turning point in the therapeutic strategy of Parkinson's disease. , 2010, CNS & neurological disorders drug targets.

[57]  D. Nicholls.  Mitochondrial ion circuits. , 2010, Essays in biochemistry.

[58]  Ted M. Dawson,et al.  Genetic Animal Models of Parkinson's Disease , 2010, Neuron.

[59]  M. Cookson,et al.  Parkinson's disease: insights from pathways. , 2010, Human molecular genetics.

[60]  S. Dubey,et al.  Bioconjugates of curcumin display improved protection against glutathione depletion mediated oxidative stress in a dopaminergic neuronal cell line: Implications for Parkinson's disease. , 2010, Bioorganic & medicinal chemistry.

[61]  L. Feng,et al.  Gene Therapy in Parkinson’s Disease , 2010, CNS drugs.

[62]  S. Lipton,et al.  Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: possible pharmacological strategies. , 2010, Cell calcium.

[63]  E. Arenas,et al.  Emerging roles of Wnts in the adult nervous system , 2010, Nature Reviews Neuroscience.

[64]  L. Chin,et al.  Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling. , 2010, Human molecular genetics.

[65]  Atsushi Tanaka,et al.  PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin , 2010, PLoS biology.

[66]  P Jeffrey Conn,et al.  Glutamate receptors as therapeutic targets for Parkinson's disease. , 2009, CNS & neurological disorders drug targets.

[67]  Hua Yu,et al.  STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.

[68]  M. Yin,et al.  Antioxidative and anti-inflammatory neuroprotective effects of astaxanthin and canthaxanthin in nerve growth factor differentiated PC12 cells. , 2009, Journal of food science.

[69]  Gene W. Yeo,et al.  Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis , 2009, Nature Neuroscience.

[70]  H. Büeler.  Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease , 2009, Experimental Neurology.

[71]  D. Standaert,et al.  Targets for neuroprotection in Parkinson's disease. , 2009, Biochimica et biophysica acta.

[72]  N. Wood,et al.  PINK1 function in health and disease , 2009, EMBO molecular medicine.

[73]  D. Sulzer,et al.  Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons , 2009, Neuron.

[74]  E. Hirsch,et al.  Neuroinflammation in Parkinson's disease: a target for neuroprotection? , 2009, The Lancet Neurology.

[75]  A. Whitworth,et al.  Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin , 2009, Cell Death and Differentiation.

[76]  E. Masliah,et al.  Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson’s disease by disturbing calcium flux , 2009, Journal of neurochemistry.

[77]  Xuebo Liu,et al.  Astaxanthin inhibits reactive oxygen species-mediated cellular toxicity in dopaminergic SH-SY5Y cells via mitochondria-targeted protective mechanism , 2009, Brain Research.

[78]  P. Kapahi,et al.  Loss-of-Function Analysis Suggests That Omi/HtrA2 Is Not an Essential Component of the pink1/parkin Pathway In Vivo , 2008, The Journal of Neuroscience.

[79]  N. Wood,et al.  What Have PINK1 and HtrA2 Genes Told Us about the Role of Mitochondria in Parkinson's Disease? , 2008, Annals of the New York Academy of Sciences.

[80]  S. Przedborski,et al.  Oxidative Stress in Parkinson's Disease , 2008, Annals of the New York Academy of Sciences.

[81]  M. Beal,et al.  Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis , 2008, Nature Clinical Practice Neurology.

[82]  A. Whitworth,et al.  Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson’s disease factors Pink1 and Parkin , 2008, Disease Models & Mechanisms.

[83]  E. Schon,et al.  The kinase domain of mitochondrial PINK1 faces the cytoplasm , 2008, Proceedings of the National Academy of Sciences.

[84]  A. Toulouse,et al.  Progress in Parkinson's disease—Where do we stand? , 2008, Progress in Neurobiology.

[85]  J. Trojanowski,et al.  Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration , 2008, The Journal of Neuroscience.

[86]  S. Tabrizi,et al.  PINK1 Is Necessary for Long Term Survival and Mitochondrial Function in Human Dopaminergic Neurons , 2008, PloS one.

[87]  D. Mochly‐Rosen,et al.  The PKCδ -Abl complex communicates ER stress to the mitochondria – an essential step in subsequent apoptosis , 2008, Journal of Cell Science.

[88]  D H Geschwind,et al.  Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation , 2008, Molecular Psychiatry.

[89]  Hey-kyeong Jeong,et al.  Resident microglia die and infiltrated neutrophils and monocytes become major inflammatory cells in lipopolysaccharide‐injected brain , 2007, Glia.

[90]  E. Alnemri.  HtrA2 and Parkinson's disease: think PINK? , 2007, Nature Cell Biology.

[91]  Chaya Brodie,et al.  The phosphorylation of tyrosine 332 is necessary for the caspase 3-dependent cleavage of PKCdelta and the regulation of cell apoptosis. , 2007, Cellular signalling.

[92]  Hitoshi Takahashi,et al.  The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates , 2007, Neuropathology : official journal of the Japanese Society of Neuropathology.

[93]  J. Downward,et al.  The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1 , 2007, Nature Cell Biology.

[94]  J. Olzmann,et al.  PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1 , 2007, PLoS biology.

[95]  P S Whitton,et al.  Inflammation as a causative factor in the aetiology of Parkinson's disease , 2007, British journal of pharmacology.

[96]  B. Bean,et al.  Roles of Subthreshold Calcium Current and Sodium Current in Spontaneous Firing of Mouse Midbrain Dopamine Neurons , 2007, The Journal of Neuroscience.

[97]  C. Olanow,et al.  Ubiquitin–proteasome system and Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[98]  Wolfgang Wurst,et al.  A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo , 2006, Development.

[99]  A. Graybiel.  The basal ganglia: learning new tricks and loving it , 2005, Current Opinion in Neurobiology.

[100]  B. Marchetti,et al.  To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders? , 2005, Trends in pharmacological sciences.

[101]  Andreas Hald,et al.  Oxidative stress and inflammation in Parkinson's disease: is there a causal link? , 2005, Experimental Neurology.

[102]  C. Marsden,et al.  Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease , 2005, Journal of Neural Transmission.

[103]  E. Alnemri,et al.  Regulation of HAX-1 Anti-apoptotic Protein by Omi/HtrA2 Protease during Cell Death* , 2004, Journal of Biological Chemistry.

[104]  Sebastian Brandner,et al.  Neuroprotective Role of the Reaper-Related Serine Protease HtrA2/Omi Revealed by Targeted Deletion in Mice , 2004, Molecular and Cellular Biology.

[105]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[106]  A. Członkowska,et al.  Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease. , 2004, International immunopharmacology.

[107]  Ke Cui,et al.  Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[108]  J. Andersen,et al.  Oxidative stress in neurodegeneration: cause or consequence? , 2004, Nature Reviews Neuroscience.

[109]  Alberto Gatti,et al.  The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[110]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[111]  Colin L. Masters,et al.  Neurodegenerative diseases and oxidative stress , 2004, Nature Reviews Drug Discovery.

[112]  Daniel Strickland,et al.  Parkinson's prevalence estimated by a state registry , 2004, Movement disorders : official journal of the Movement Disorder Society.

[113]  M. Kitazawa,et al.  Proteolytic Activation of Proapoptotic Kinase PKCδ Is Regulated by Overexpression of Bcl‐2 , 2003 .

[114]  S. Srinivasula,et al.  Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice , 2003, Nature.

[115]  M. Beal.  Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.

[116]  Roberto Colombo,et al.  Protein carbonylation in human diseases. , 2003, Trends in molecular medicine.

[117]  D. Lahiri,et al.  Proteolytic activation of proapoptotic kinase PKCdelta is regulated by overexpression of Bcl-2: implications for oxidative stress and environmental factors in Parkinson's disease. , 2003, Annals of the New York Academy of Sciences.

[118]  J. Yabut,et al.  Glutathione depletion and oxidative stress. , 2002, Parkinsonism & related disorders.

[119]  E. Esposito,et al.  A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes , 2002, Neurobiology of Aging.

[120]  Emad S. Alnemri,et al.  Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi , 2002, Nature Structural Biology.

[121]  E. Masliah,et al.  α-Synuclein is phosphorylated in synucleinopathy lesions , 2002, Nature Cell Biology.

[122]  Patrik Brundin,et al.  Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. , 2002, Nature reviews. Neuroscience.

[123]  E. Masliah,et al.  alpha-Synuclein is phosphorylated in synucleinopathy lesions. , 2002, Nature cell biology.

[124]  David Blum,et al.  Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease , 2001, Progress in Neurobiology.

[125]  E. Melamed,et al.  Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier , 2001, Neuropharmacology.

[126]  D. Kufe,et al.  The ARG Tyrosine Kinase Interacts with Siva-1 in the Apoptotic Response to Oxidative Stress* , 2001, The Journal of Biological Chemistry.

[127]  E. Joe,et al.  Thrombin Induces NO Release from Cultured Rat Microglia via Protein Kinase C, Mitogen-activated Protein Kinase, and NF-κB* , 2000, The Journal of Biological Chemistry.

[128]  Shinsei Minoshima,et al.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.

[129]  H. Braak,et al.  Pathoanatomy of Parkinson’s disease , 2000, Journal of Neurology.

[130]  Y. Naguib.  Antioxidant activities of astaxanthin and related carotenoids. , 2000, Journal of agricultural and food chemistry.

[131]  D. Kufe,et al.  Interaction between Protein Kinase C δ and the c-Abl Tyrosine Kinase in the Cellular Response to Oxidative Stress* , 2000, The Journal of Biological Chemistry.

[132]  M. Selley.  (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease. , 1998, Free radical biology & medicine.

[133]  E. Joe,et al.  Mitogen‐activated protein kinases activated by lipopolysaccharide and β‐amyloid in cultured rat microglia , 1998 .

[134]  C D Marsden,et al.  Oxidative DNA Damage in the Parkinsonian Brain: An Apparent Selective Increase in 8‐Hydroxyguanine Levels in Substantia Nigra , 1997, Journal of neurochemistry.

[135]  A. Schapira.  OXIDATIVE STRESS IN PARKINSONS-DISEASE , 1995 .

[136]  L. Forno.  The Lewy body in Parkinson's disease. , 1987, Advances in neurology.

[137]  J. Langston,et al.  1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra , 1984, Neuroscience Letters.

[138]  J. Mussini,et al.  [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.